SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001836379-22-000002
Filing Date
2022-05-04
Accepted
2022-05-04 08:00:09
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-3 vectiv-fx3cooleydraft5222.htm F-3 738541
2 EX-FILING FEES vectiv-fx3filingfeeexhibit.htm EX-FILING FEES 24937
3 EX-1.2 vectivbio-salesagentagreem.htm EX-1.2 342552
4 EX-4.1 vbhagstatutenexecutionvers.htm EX-4.1 417115
5 EX-4.2 vectivbio-fx3xformofindent.htm EX-4.2 359193
6 EX-5.1 projectvikinglegalopinione.htm EX-5.1 33680
7 EX-5.2 vectiv-fx352opinion1.htm EX-5.2 41820
8 EX-23.1 auditorconsent.htm EX-23.1 2262
9 image_0.jpg GRAPHIC 2841
10 image_1b.jpg GRAPHIC 8359
11 image_2.jpg GRAPHIC 10171
12 image_3.jpg GRAPHIC 94249
  Complete submission text file 0001836379-22-000002.txt   2120347
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 41 61 551 30 30
VectivBio Holding AG (Filer) CIK: 0001836379 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-264653 | Film No.: 22889866
SIC: 2836 Biological Products, (No Diagnostic Substances)